
    
      This is a prospective, non-randomized post market study designed to evaluate fusion and pain
      reduction following the use of the SImmetry System. This study will be conducted at up to 40
      sites and 250 total subjects will be enrolled and followed through 24 months. Data will be
      collected pre-operatively, implant, and at specified follow-up time points through 24 months.
    
  